| # | Drug | Count |
|---|---|---|
| 0 | VEDOLIZUMAB | 10 |
| 1 | ADALIMUMAB | 7 |
| 2 | ADALIMUMAB-AATY | 7 |
| 3 | ADALIMUMAB-ADAZ | 7 |
| 4 | ADALIMUMAB-FKJP | 7 |
| 5 | USTEKINUMAB | 5 |
| 6 | BUDESONIDE | 3 |
| 7 | AZATHIOPRINE | 2 |
| 8 | ERGOCALCIFEROL | 2 |
| 9 | INFLIXIMAB | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PSYLLIUM HUSK | 1 | 0.0007 |
| 1 | FERRIC DERISOMALTOSE | 1 | 0.0007 |
| 2 | ADALIMUMAB-FKJP | 7 | 0.0002 |
| 3 | ADALIMUMAB-AATY | 7 | 0.0001 |
| 4 | ADALIMUMAB-ADAZ | 7 | 0.0001 |
| 5 | VEDOLIZUMAB | 10 | 0.0001 |
| 6 | CHOLESTYRAMINE | 1 | 0.0001 |
| 7 | TOFACITINIB CITRATE | 1 | 0.0001 |
| 8 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 1 | 0.0001 |
| 9 | MESALAMINE | 2 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Integrin Receptor Antagonist [EPC] | 10 | 0.0001 |
| 1 | Bile Acid Sequestrant [EPC] | 1 | 0.0001 |
| 2 | Provitamin D2 Compound [EPC] | 2 | 0.0001 |
| 3 | Interleukin-12 Antagonist [EPC] | 5 | 0.0000 |
| 4 | Interleukin-23 Antagonist [EPC] | 5 | 0.0000 |
| 5 | Purine Antimetabolite [EPC] | 2 | 0.0000 |
| 6 | Aminosalicylate [EPC] | 2 | 0.0000 |
| 7 | Nitroimidazole Antimicrobial [EPC] | 1 | 0.0000 |
| 8 | Tetracycline-class Drug [EPC] | 1 | 0.0000 |
| 9 | Tumor Necrosis Factor Blocker [EPC] | 7 | 0.0000 |